IL289109B2 - Isoxazoline formulations against parasites and methods for treating blepharitis - Google Patents
Isoxazoline formulations against parasites and methods for treating blepharitisInfo
- Publication number
- IL289109B2 IL289109B2 IL289109A IL28910921A IL289109B2 IL 289109 B2 IL289109 B2 IL 289109B2 IL 289109 A IL289109 A IL 289109A IL 28910921 A IL28910921 A IL 28910921A IL 289109 B2 IL289109 B2 IL 289109B2
- Authority
- IL
- Israel
- Prior art keywords
- composition
- blepharitis
- formulation
- treating
- configurations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
- A01N43/80—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Polymers & Plastics (AREA)
- Ophthalmology & Optometry (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Environmental Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Dentistry (AREA)
- Birds (AREA)
- Agronomy & Crop Science (AREA)
- Wood Science & Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962863822P | 2019-06-19 | 2019-06-19 | |
| US202063029689P | 2020-05-25 | 2020-05-25 | |
| PCT/US2020/038758 WO2020257663A1 (fr) | 2019-06-19 | 2020-06-19 | Formulations parasiticides à base d'isoxazoline et procédés de traitement de blépharite |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| IL289109A IL289109A (en) | 2022-02-01 |
| IL289109B1 IL289109B1 (en) | 2025-06-01 |
| IL289109B2 true IL289109B2 (en) | 2025-10-01 |
Family
ID=74040459
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL289109A IL289109B2 (en) | 2019-06-19 | 2020-06-19 | Isoxazoline formulations against parasites and methods for treating blepharitis |
| IL321061A IL321061A (en) | 2019-06-19 | 2020-06-19 | Isoxazoline parasiticide formulations and methodsfor treating blepharitis |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL321061A IL321061A (en) | 2019-06-19 | 2020-06-19 | Isoxazoline parasiticide formulations and methodsfor treating blepharitis |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP3986377A4 (fr) |
| JP (2) | JP2022537389A (fr) |
| KR (1) | KR20220053550A (fr) |
| CN (1) | CN114269324A (fr) |
| AU (1) | AU2020295570A1 (fr) |
| BR (1) | BR112021025701A2 (fr) |
| CA (1) | CA3144264A1 (fr) |
| IL (2) | IL289109B2 (fr) |
| MX (1) | MX2021016055A (fr) |
| WO (1) | WO2020257663A1 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016022066A1 (fr) | 2014-08-04 | 2016-02-11 | Jerry Tan Eye Surgery Pte Ltd | Compositions pharmaceutiques pour blépharite et encroûtement des paupières liés à demodex |
| AU2018385766B2 (en) | 2017-12-15 | 2022-12-01 | Tarsus Pharmaceuticals, Inc. | Isoxazoline parasiticide formulations and methods for treating blepharitis |
| WO2022156371A1 (fr) * | 2021-01-22 | 2022-07-28 | 成都瑞沐生物医药科技有限公司 | Support ou substance auxiliaire de préparation ophtalmique, son procédé de préparation et son application |
| US20220323472A1 (en) * | 2021-03-30 | 2022-10-13 | Frank Anthony SPALLITTA | Anti-parasitic compounds for the treatment and prevention of viral diseases |
| PL4312986T3 (pl) * | 2021-04-01 | 2025-02-17 | Active Biotech Ab | Preparat lakwinimodu do stosowania do oczu |
| WO2024168149A1 (fr) * | 2023-02-10 | 2024-08-15 | Tarsus Pharmaceuticals, Inc. | Formulations parasiticides à base d'isoxazoline et méthodes de traitement de la blépharite |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090317503A1 (en) * | 2008-06-20 | 2009-12-24 | Ocusoft, Inc. | Eyelid Preparation and Method of Use |
| US20120053140A1 (en) * | 2005-09-30 | 2012-03-01 | Galderma S.A. | Administration of avermectin/milbemycin compounds for the treatment of ophthalmic pathologies |
| US20130324538A1 (en) * | 2011-02-10 | 2013-12-05 | Noëlle Gauvry | Isoxazoline derivatives for controlling invertebrate pests |
| US20160317439A1 (en) * | 2013-12-20 | 2016-11-03 | Intervet Inc. | Isoxazoline compositions and use thereof in the prevention or treatment of parasite infestations in animals |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090214676A1 (en) * | 2005-04-30 | 2009-08-27 | Tissuetech, Inc. | Method for treating ocular demodex |
| JP5246182B2 (ja) * | 2010-02-24 | 2013-07-24 | ライオン株式会社 | 点眼剤、防腐剤及び防腐力向上剤 |
| BR112012026364B1 (pt) * | 2010-04-12 | 2018-04-10 | Exosect Limited | Controle de artrópodes em ambientes de animais |
| WO2016022066A1 (fr) * | 2014-08-04 | 2016-02-11 | Jerry Tan Eye Surgery Pte Ltd | Compositions pharmaceutiques pour blépharite et encroûtement des paupières liés à demodex |
| AU2018385766B2 (en) * | 2017-12-15 | 2022-12-01 | Tarsus Pharmaceuticals, Inc. | Isoxazoline parasiticide formulations and methods for treating blepharitis |
| JP7569781B2 (ja) * | 2018-07-27 | 2024-10-18 | アペルタ バイオサイエンシズ,エルエルシー | デモデックスにより誘発される眼の異常および顔面の異常を治療するためのスピノシン配合 |
-
2020
- 2020-06-19 IL IL289109A patent/IL289109B2/en unknown
- 2020-06-19 CN CN202080050179.5A patent/CN114269324A/zh active Pending
- 2020-06-19 JP JP2021575891A patent/JP2022537389A/ja active Pending
- 2020-06-19 CA CA3144264A patent/CA3144264A1/fr active Pending
- 2020-06-19 EP EP20826079.4A patent/EP3986377A4/fr active Pending
- 2020-06-19 IL IL321061A patent/IL321061A/en unknown
- 2020-06-19 KR KR1020227001984A patent/KR20220053550A/ko active Pending
- 2020-06-19 WO PCT/US2020/038758 patent/WO2020257663A1/fr not_active Ceased
- 2020-06-19 MX MX2021016055A patent/MX2021016055A/es unknown
- 2020-06-19 AU AU2020295570A patent/AU2020295570A1/en active Pending
- 2020-06-19 BR BR112021025701A patent/BR112021025701A2/pt unknown
-
2025
- 2025-07-10 JP JP2025116873A patent/JP2025137609A/ja active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120053140A1 (en) * | 2005-09-30 | 2012-03-01 | Galderma S.A. | Administration of avermectin/milbemycin compounds for the treatment of ophthalmic pathologies |
| US20090317503A1 (en) * | 2008-06-20 | 2009-12-24 | Ocusoft, Inc. | Eyelid Preparation and Method of Use |
| US20130324538A1 (en) * | 2011-02-10 | 2013-12-05 | Noëlle Gauvry | Isoxazoline derivatives for controlling invertebrate pests |
| US20160317439A1 (en) * | 2013-12-20 | 2016-11-03 | Intervet Inc. | Isoxazoline compositions and use thereof in the prevention or treatment of parasite infestations in animals |
Also Published As
| Publication number | Publication date |
|---|---|
| CA3144264A1 (fr) | 2020-12-24 |
| CN114269324A (zh) | 2022-04-01 |
| IL289109A (en) | 2022-02-01 |
| EP3986377A1 (fr) | 2022-04-27 |
| WO2020257663A1 (fr) | 2020-12-24 |
| EP3986377A4 (fr) | 2023-07-19 |
| IL321061A (en) | 2025-07-01 |
| JP2025137609A (ja) | 2025-09-19 |
| KR20220053550A (ko) | 2022-04-29 |
| BR112021025701A2 (pt) | 2022-03-03 |
| JP2022537389A (ja) | 2022-08-25 |
| IL289109B1 (en) | 2025-06-01 |
| MX2021016055A (es) | 2022-04-20 |
| AU2020295570A1 (en) | 2022-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12364685B2 (en) | Isoxazoline parasiticide formulations | |
| IL289109B2 (en) | Isoxazoline formulations against parasites and methods for treating blepharitis | |
| US20220249445A1 (en) | Isoxazoline parasiticide formulations and methods for treating blepharitis | |
| RU2846812C2 (ru) | Изоксазолиновые паразитицидные составы и способы лечения блефарита | |
| WO2024168149A1 (fr) | Formulations parasiticides à base d'isoxazoline et méthodes de traitement de la blépharite | |
| HK40070706A (en) | Isoxazoline parasiticide formulations and methods for treating blepharitis |